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PROMIS Physical Function Has a Lower Effect Size
and is Less Responsive than Legacy Hip Speciﬁc
Patient Reported Outcome Measures Following
Arthroscopic Hip Surgery
Benedict U. Nwachuwu, M.D., M.B.A., Jonathan Rasio, B.S.,
Edward C. Beck, M.D., M.B.A., Kelechi R. Okoroha, M.D., Spencer W. Sullivan, B.S.,
Eric C. Makhni, M.D., and Shane J. Nho, M.D., M.S.

Purpose: To compare the use and responsiveness of Patient Reported Outcomes Measurement Information System
(PROMIS) to legacy patient-reported outcome measures (PROMs) in patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) at 6-month follow-up. Methods: Data from patients who underwent
primary hip arthroscopy with routine capsular closure between August 2018 and January 2019 for the treatment of FAIS
were analyzed. Preoperative outcomes, 6-month postoperative outcomes, and demographics were recorded. Primary
outcome measures included PROMIS Physical Function (PROMIS-PF), PROMIS Pain Interference (PROMIS-PI), and
PROMIS Depression. The legacy PROMs included Hip Outcome Score Activities of Daily Living (HOS-ADL), Hip Outcome
Score Sport Subscale (HOS-SS), and the international hip outcome tool 12 questions (iHOT-12). Floor and ceiling effects
along with the responsiveness and Cohen’s d effect size of each PROM tool were calculated. Results: Ninety-six patients
with an average age and body mass index of 32.4  11.9 years and 25.9  6.1 kg/m2, respectively, were included in the
ﬁnal analysis. All outcomes were signiﬁcantly higher at 6 months compared with the preoperative level (P < .001) except
for PROMIS Depression (P ¼ .873). PROMIS-PF demonstrated excellent correlation with HOS-SS (r ¼ 0.81; P < .001),
very good correlation with HOS-ADL (r ¼ 0.73; P < .001), and good correlation with iHOT-12 (r ¼ 0.68; P < .001). No
ﬂoor was observed for any measure. The effect size was large for all outcomes, except PROMIS Depression (d ¼ 0.04), but
largest for iHOT12 (d ¼ 1.87) followed by HOS-ADL (d ¼ 1.29). The iHOT-12 was more responsive than PROMIS-PI
(relative efﬁciency [RE] ¼ 3.95), PROMIS-PF (RE ¼ 4.13), HOS-ADL (RE ¼ 2.26), and HOS-SS (RE ¼ 3.84). HOS-SS
was similarly responsive to PROMIS-PI (RE¼1.03) and PROMIS-PF (RE¼1.08). However, PROMIS-PF was overall the
least responsive. Conclusions: In patients at 6 months postoperatively from hip arthroscopy for FAIS, iHOT-12 was the
most responsive and had the largest effect size. In contrast, PROMIS-PF had a lower effect size compared with legacy hipspeciﬁc PROMs. Additionally, PROMIS-PF did not correlate as well with iHOT-12 compared with HOS-SS. Level of
Evidence: Level IV, case series.

T

here is increasing attention to streamlining
methods for patient-reported outcome collection
and delivery. The Patient Reported Outcomes Measurement Information System (PROMIS) was developed

by the National Institutes of Health with the goal of
providing a single, generalizable, and validated outcome
measure that can be administered across a number of
conditions.1 More recently, computer adaptive testing

From the Department of Orthopaedic Surgery, Hospital for Special Surgery
(B.U.N., E.C.B., S.W.S.), New York, New York, U.S.A.; Division of Sports
Medicine, Midwest Orthopaedics at Rush, Rush University Medical Center (J.R.,
S.J.N.), Chicago, Illinois, U.S.A.; and Department of Orthopaedic Surgery,
Henry Ford Health Center (K.R.O., E.C.M.), Detroit, Michigan, U.S.A.
The authors report the following potential conﬂicts of interest or sources of
funding: S.J.N. reports personal fees from Stryker, American Journal of Orthopedics, and Ossur. Full ICMJE author disclosure forms are available for
this article online, as supplementary material.

Received January 31, 2020; accepted July 3, 2020.
Address correspondence to Benedict U. Nwachukwu, M.D., M.B.A.,
Department of Orthopaedic Surgery, Hospital for Special Surgery, 610 W.
58th St., 3rd Floor, New York, NY 10019. E-mail: nwachukwub@hss.edu
Ó 2020 by the Arthroscopy Association of North America
0749-8063/2091/$36.00
https://doi.org/10.1016/j.arthro.2020.07.008

Arthroscopy: The Journal of Arthroscopic and Related Surgery, Vol

-,

No

-

(Month), 2020: pp 1-6

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on August 18, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.

1

2

B. U. NWACHUWU ET AL.

(CAT) versions of PROMIS instruments have been
developed that use item selection to reduce the number
of responses required to provide an outcome score
assessment.1-4
There is increasing interest in understanding the performance of PROMIS for evaluating orthopaedic conditions.5 The psychometric properties of PROMIS have
been studied for knee meniscal surgery, rotator cuff
abnormalities, shoulder arthritis, shoulder instability,
femoroacetabular impingement syndrome (FAIS), and
anterior cruciate ligament injuries.6-12 Although the
majority of prior studies have suggested good correlation
between PROMIS and legacy outcome measures, some
authors have suggested that PROMIS is inherently
anchored to the preferences of a United States-based
population and may lack the generalizability required
of a “gold standard.”13 Speciﬁc to hip pain, 2 prior
studies have evaluated the preoperative psychometric
properties of PROMIS for patients presenting at a hip
preservation center. Both studies demonstrated that
PROMIS-PF demonstrated excellent to good correlation
preoperatively with legacy hip-speciﬁc instruments as
well as with health-related quality of life measures.11,12
However, a study speciﬁc to FAIS noted that PROMIS
Physical Function (PROMIS-PF) demonstrated the
weakest correlation with the Hip Outcome Score Sports
Speciﬁc subscale.12 The authors theorized that there is “a
component of hip-speciﬁc disability that is not captured
in the PROMIS-PF.”
In the hip preservation evidence base, there is a
paucity of longitudinal and postoperative PROMIS data.
As such, there is an opportunity to evaluate the early
postoperative performance of PROMIS-PF CAT in
patients undergoing arthroscopic FAIS surgery. The
purpose of this study was to compare the use and
responsiveness, which refers to the ability of an
outcome measure to detect change over time, of
PROMIS to legacy patient-reported outcome measures
(PROMs) in patients undergoing hip arthroscopy for
FAIS at 6-month follow-up. The authors hypothesize
that PROMIS will demonstrate good correlation; however, the authors predict that there may be limited
responsiveness for PROMIS compared with legacy
PROMs.

Methods
Patient Selection
The current study was approved by the Rush University Medical Center institutional review board. Data
were prospectively collected on all patients undergoing
hip arthroscopy for the treatment of FAIS by a single,
fellowship-trained surgeon (S.J.N.). Data were retrospectively analyzed in a clinical repository. Consecutive
patients undergoing primary hip arthroscopy for the
treatment of FAIS between August 2018 and January

2019 were included in this study. Inclusion criteria
consisted of clinical and radiographic diagnosis of
symptomatic FAIS, failure of conservative management
(including physical therapy, activity modiﬁcation, oral
anti-inﬂammatories, and/or intra-articular cortisone injection), and surgical treatment with hip arthroscopy for
FAIS.14 Exclusion criteria consisted of prior history of
bilateral hip surgery, hip arthroscopy for an indication
other than FAIS, signs of osteoarthritis (Tonnis grade
>1), hip dysplasia (Lateral Center Edge Angle <20 ),15 a
history of pediatric hip disorders (eg, slipped capital
femoral epiphysis, hip dysplasia, Perthes disease, etc.),
concomitant trochanteric bursectomy, and concomitant
gluteus medius/minimus repair.
Functional Outcome Evaluation
Preoperatively, demographic data were collected from
all patients, including sex, age, operative extremity, body
mass index, sports participation, duration of symptoms,
and comorbidities. All patients completed preoperative
and minimum 6 months of legacy hip-speciﬁc PROMs
including the Hip Outcome Score Activities of Daily Living
Subscale (HOS-ADL),16 HOS-Sports Subscale (HOS-SS),
and the International Hip Outcome Tool-12 (iHOT-12).17
Nwachukwu et al18 previously demonstrated that a high
proportion of patients achieved signiﬁcant clinical outcomes in legacy PROMs, iHOT-33, HOS-ADL, and
HOS-SS at the 6-month postoperative follow-up. In
addition, primary outcome measures, PROMIS-PF,
PROMIS Pain Interference (PROMIS-PI),19,20 and
PROMIS Depression,21 were obtained via CAT. Questionnaires were completed using Outcome Based Electronic Research Database (Universal Research Solutions,
Columbia, MO).
Statistical Analysis
Analysis was performed to identify any existing ﬂoor
and ceiling effects for the legacy hip-speciﬁc PROMs,
PROMIS-PF, PROMIS-PI, and PROMIS Depression. For
the legacy PROMs, which are scaled to 100, any percentage greater or equal to 15% of the study population
in the top or bottom 5% of the score range was deemed
as a signiﬁcant ceiling or ﬂoor effect.6,22 For PROMIS, a
signiﬁcant ﬂoor or ceiling effect for PROMIS outcomes
was determined as any percentage greater or equal to
15% of the study population in the top or bottom 5th
percentile of the population was deemed as signiﬁcant
ceiling or ﬂoor effect.6,22
All data were screened to determine the achievement
of all parametric statistical assumptions before analysis.
Pearson coefﬁcient analysis was used to identify correlations between PROMIS scores and the legacy PROMs.
Correlation coefﬁcients were classiﬁed by the strength of
the correlation, which were deﬁned as follows: excellent
(>0.80), very good (0.71-0.80), good (0.61-0.70), fair
(0.41-0.60), and poor (0.21-0.40).17
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Table 1. Patient Demographics
Mean (SD)/No. (%)
96
32.4  11.9
76 (79.2)
25.9  6.1

N
Age (y)
Females
BMI

BMI, body mass index; SD, standard deviation.

To directly compare the responsiveness between
PROMs, the effect size and relative efﬁciency (RE) were
calculated for each PROM tool.23-25 The effect size, or
Cohen’s d, is a measure of the magnitude of the preoperative to postoperative change in relation to the
amount of variability in the scores.25-27 Cohen’s d was
calculated by dividing the absolute difference in the
mean change score for each PROM by the pooled
standard deviation for that PROM tool.25-27 Consequently, a d of 1 means that the pre- to postoperative
change in a PROM differs by 1 standard deviation. Effect sizes between 0.20 and 0.49 are considered small,
between 0.50 and 0.79 are considered moderate, and
0.80 are considered large and are clearly visible to the
naked eye.25-27 The RE was calculated to directly
compare responsiveness between PROM tools.23-25 The
RE is derived from the resultant t score for paired t tests
comparing the preoperative score for a PROM tool with
the postoperative score. The t score from 1 PROM tool is
then divided by the t score of another PROM tool and
the resulting value is squared to obtain the RE between
the 2 PROMs.23-25 If the RE is <1, the ﬁrst PROM tool
would be considered “less responsive” than the second
PROM tool. Conversely, if the RE is >1, the ﬁrst PROM
would be considered “more responsive” than the second PROM tool.23-25
Descriptive statistics for all continuous variables are
reported as means with standard deviations, and frequency statistics are reported for all noncontinuous
variables. Paired samples t tests were used to compare
preoperative and 6-month postoperative PROMs in FAIS
patients. All continuous data were screened for
normality using the Shapiro-Wilk test and all data were
found to be drawn from a normal distribution. This
allowed us to use parametric tests such as Pearson’s
correlation and Student t test. In addition, Levene’s test
was used to test for homogeneity of variance in cases
where the pooled standard deviation had to be calculated. Statistical signiﬁcance for all analyses was set at an
a  0.05. All statistical analyses were performed using
JMP PROM (version 14.2, SAS Institute, Cary, NC).

Results
Of 140 eligible patients, 13 underwent revision surgery and 7 underwent concomitant gluteus medius
repair and were excluded from the study. A total of 96
patients (80%) had 6-month follow-up and were

included in the study, with an average age and body
mass index of 32.4  11.9 years and 25.9  6.1 kg/m2,
respectively. Patient demographics are summarized in
Table 1. The majority of patients were female (76%).
There were no workers compensation patients in this
cohort. All patients underwent primary labral repair,
acetabular rim trimming, debridement, synovectomy,
femoral osteochondroplasty, and capsular closure.
Clinical Outcomes Analysis
Using PROMIS CAT, patients answered between 4 and
12 questions with an average of 5.0, 5.7, and 4.4
questions for PI, Depression, and PF, respectively. Paired
t test analysis of pre- and minimum 6-months postoperative PROMs are summarized in Table 2. There was
a statistically signiﬁcant increase in mean HOS-ADL
(62.7  16.1 vs 83.1  15.3; P < .001), HOS-SS (39.1
 21.0 vs 64.7  26.5; P < .001), iHOT-12, (29.2  18.3
vs 68.0  23.0; P < .001), and PROMIS-PF (40.3  6.4
vs 47.1  7.9; P ¼ .003). In addition, there was a signiﬁcant reduction in reported mean PROMIS-PI score
(61.3  5.8 vs 54.6  8.0; P ¼ .004). There was no
statistical difference in reported mean PROMIS depression scores (48.8  8.6 vs 49.2  8.2; P < .87).
Floor and ceiling effects at 6-months postoperatively
for PROM tools are summarized in Table 3. There was a
ceiling effect observed for HOS-ADL, with 24.44% in
the top 5% of possible scores, and for PROMIS-PI, with
15.22% in the top 5th percentile. No ﬂoor effect was
observed for any measure.
Correlation Analysis
Pearson’s coefﬁcient analysis between PROMIS
outcome and legacy PROMs score are summarized in
Table 4. PROMIS-PF scores demonstrated excellent correlation with HOS-SS (r ¼ 0.81; P < .001), very good
correlation with HOS-ADL (r ¼ 0.73; P < .001), and good
correlation with iHOT-12 (r ¼ 0.68; P < .001). PROMISPI demonstrated very good correlation with HOS-ADL
(r ¼ -0.78; P < .001), HOS-SS (r ¼ -0.74; P < .001),
and iHOT12 (r ¼ -0.77; P < .001). PROMIS Depression
demonstrated fair correlation with HOS-ADL (r ¼ -0.46;
Table 2. Analysis of Pre- and Postoperative Reported
Outcomes
Preoperative
HOS-ADL ( SD)
62.7  16.1
HOS-SS ( SD)
39.1  21.0
iHOT-12 ( SD)
29.2  18.3
PROMIS depression ( SD)
48.8  8.6
PROMIS Pain interference ( SD) 61.3  5.8
PROMIS Physical function ( SD) 40.3  6.4

6 mo
83.1  15.3
64.7  26.5
68.0  23.0
49.2  8.2
54.6  8.0
47.1  7.9

P Value
<.001*
<.001*
<.001*
.873
.004*
0.003*

HOS-ADL, Hip Outcome Score-Activities of Daily Living; HOS-SS,
Hip Outcome Score-Sports Subscale; iHOT-12, International Hip
Outcome Tool 12; PROMIS, Patient Reported Outcomes Measurement Information System; SD, standard deviation.
*Statistical signiﬁcance with P < .01.
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Table 3. Postoperative Outcomes Floor and Ceiling Effects
HOS-ADL
HOS-SS
iHOT-12
PROMIS Depression
PROMIS Pain Interference
PROMIS Physical Function

Floor (%)
0
2.67
0
10.34
0
8.79

Ceiling (%)
24.44
8.00
4.26
4.60
15.22
2.20

Boldface type indicates >15% of patient outcomes in the bottom or
top 5th percentile for ﬂoor and ceiling, respectively.
HOS-ADL, Hip Outcome Score-Activities of Daily Living; HOS-SS,
Hip Outcome Score-Sports Subscale; iHOT-12, International Hip
Outcome Tool 12; PROMIS, Patient Reported Outcomes Measurement Information System.

P < .001), HOS-SS (r ¼ -0.46; P < .001), and iHOT12
(r ¼ -0.43; P < .001).
Responsiveness Analysis
The pooled effect sizes for each PROM are summarized
in Table 5. Overall, the PROMIS outcomes had smaller
differences between mean pre- and postoperative outcomes compared with the legacy PROMs, but were also
more precise with standard deviations 2 to 3 times
smaller than the legacy PROMs. The pooled effect size
was considered large and visible to the naked eye for all
PROMs except PROMIS Depression (d ¼ 0.04). However, the effect size was largest for iHOT12 (d ¼ 1.87)
followed by HOS-ADL (d ¼ 1.29). PROMIS-PI, PROMISPF, and HOS-SS had very similar effect sizes of d ¼ 0.96,
d ¼ 0.94, and d ¼ 1.06, respectively.
Based on the results of the correlation analysis and effect
size, PROMIS Depression was not included in the
comparative responsiveness analysis. The RE between
outcomes are summarized in Table 6. If the value is >1, the
PROM tool on the left column is deﬁned as more responsive
than the respective PROM tool on the top row. The iHOT12 was more responsive than PROMIS-PI (RE ¼ 3.95),
PROMIS-PF (RE ¼ 4.13), HOS-ADL (RE ¼ 2.26), and
HOS-SS (RE ¼ 3.84). In contrast, HOS-SS was similarly
responsive to PROMIS-PI (RE ¼ 1.03) and PROMIS-PF
(RE ¼ 1.08); however, PROMIS-PF was overall the least
responsive across all outcome comparisons.

Discussion
In this study, we found that both PROMIS-PF and
PROMIS-PI demonstrate good to excellent correlation

with legacy hip-speciﬁc PROMs. We also found that at
minimum 6-month follow-up there were no ﬂoor
effects on any PROM; however, HOS-ADL and
PROMIS-PI demonstrated signiﬁcant ceiling effects.
When comparing responsiveness, we found that the
effect size was large for all outcomes, except PROMIS
Depression, but largest for the iHOT-12. PROMIS-PF
was overall the least responsive and the iHOT-12 was
more responsive than PROMIS-PI, PROMIS-PF,
HOS-ADL, and HOS-SS. In contrast, HOS-SS was
similarly responsive to PROMIS-PF and PROMIS-PI.
These ﬁndings conﬁrm our hypotheses.
Few studies have previously evaluated the psychometric properties of PROMIS in patients undergoing
arthroscopic FAIS. Sheean et al28 ﬁrst reported PROMIS
scores in 20 patients with FAIS, compared with 22
asymptomatic patients. The authors demonstrated that
PROMIS scores were signiﬁcantly different between
FAIS patients and asymptomatic controls. The authors
therefore proposed that PROMIS was useful for
capturing disability associated with FAIS.27 More
recently, Kollmorgen et al11 investigated the psychometrics of PROMIS in a mixed population of 125 patients
presenting to a tertiary care hip preservation center. The
authors reported strong positive Spearman correlations
between PROMIS-PF scores and hip-speciﬁc legacy
scores, iHOT-12, HOS, modiﬁed Harris Hip Score, and
Veterans RAND-6D (VR-6D). However only 55% of
patients were post-surgical (mean follow-up of 5.2
months) and the compositions of surgical procedures
was quite heterogeneous.11 Nwachukwu et al12 evaluated the preoperative performance of PROMIS-PF in 197
nonoperative patients with FAIS. The authors found
good to excellent Pearson correlations between PROMIS
and the following hip-speciﬁc legacy scores: iHOT-12,
HOS-ADL, HOS-SS, and modiﬁed Harris Hip Score.
Each PROM was measured preoperatively in a cohort
with 100% diagnosis of FAIS indicated for hip arthroscopic surgery.12 The study, however, was limited by a
lack of postoperative follow-up and analysis.
In this study, we found that PROMIS-PF correlated
well with legacy hip-speciﬁc PROMs with the best
correlation demonstrated for HOS-SS and HOS-ADL.
Interestingly, PROMIS-PF did not correlate as well
with iHOT-12. These ﬁndings are somewhat in contrast
to the prior ﬁndings reported by Nwachukwu et al12

Table 4. Correlation Analysis of Postoperative Reported Outcomes
HOS-ADL
HOS-SS
iHOT-12

PROMIS Physical Function (r)
0.732
0.810
0.679

P Value
<.001*
<.001*
<.001*

PROMIS Pain Interference (r)
-0.781
-0.741
-0.770

P Value
<.001*
<.001*
<.001*

PROMIS Depression (r)
-0.457
-0.455
-0.426

P Value
<.001*
<.001*
<.001*

HOS-ADL, Hip Outcome Score-Activities of Daily Living; HOS-SS, Hip Outcome Score-Sports Subscale; iHOT-12, International Hip Outcome
Tool 12; PROMIS, Patient Reported Outcomes Measurement Information System.
*Statistical signiﬁcance with P < .01.
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Table 5. Pre- vs Postoperative Outcome Score Difference and
Pooled Effect Size

PROMIS Pain Interference
PROMIS Depression
PROMIS Physical Function
HOS-ADL
HOS-SS
iHOT-12

Mean Score
Difference
-6.67
0.37
6.79
20.37
25.29
38.82

Pooled SD
6.99
8.39
7.21
15.75
23.93
20.77

Pooled Effect
Size (d)
0.96
0.04
0.94
1.29
1.06
1.87

HOS-ADL, Hip Outcome Score-Activities of Daily Living; HOS-SS,
Hip Outcome Score-Sports Subscale; iHOT-12, International Hip
Outcome Tool 12; PROMIS, Patient Reported Outcomes Measurement Information System; SD, standard deviation.

because, in the present study, HOS-SS demonstrates the
best correlation with PROMIS. This suggests that
although the HOS-SS may only demonstrate good
correlation with PROMIS-PF preoperatively, by the
postoperative time point HOS-SS and PROMIS-PF may
demonstrate excellent correlation. In contrast however,
iHOT-12, as demonstrated in the prior Nwachukwu
et al12 study, has excellent preoperative correlation
with PROMIS-PF but by the postoperative time point
iHOT-12 demonstrated only good correlation, representing a substantial drop. These ﬁndings are important
as we consider how PROMIS-PF can replace legacy
measures. Speciﬁcally, the described trend may lend
credence to the notion that PROMIS-PF may not fully
capture all aspects of hip-speciﬁc disability compared
with other joint speciﬁc forms. Additionally, there may
also be a dynamic nature to symptomatology of FAIS as
captured by PROMIS and legacy PROMs.
Beyond correlational analysis, we also evaluated the
responsiveness of PROMIS and legacy PROMs. Responsiveness is a key factor that describes how the PROM is
able to track clinically important changes longitudinally.22,29 The validity of iHOT-12 is supported because it
is able to detect minimally important change in a clinical
setting.30 In this study, we found that the iHOT-12 is the
most responsive of hip-speciﬁc PROMs and is more
responsive than PROMIS-PF. In contrast, however, we
found that PROMIS-PF is the least responsive. These
ﬁndings suggest that among legacy hip-speciﬁc PROMs,
the iHOT-12 should be preferentially administered

alongside PROMIS because of its large effect size and
strong responsiveness. Although our study ﬁndings
highlight that PROMIS is lacking as a disease-speciﬁc
outcome measure in the hip preservation population,
we do believe that there is a role for the collection of
PROMIS in these patients. Ultimately, PROMIS instruments can provide comparability across disease states
and procedures, thereby allowing for collection of
normative data. Widely applicable instruments such as
PROMIS can provide beneﬁts for patient counseling and
implementation of health policy initiatives. As such, we
counsel against replacing legacy hip-speciﬁc measures
but rather administering PROMIS measures as an
adjunct.
Limitations
The current study has certain limitations worth
noting. The major limitation in this study is the limited
follow-up of 6 months postoperatively. We can support
the use of PROMIS and how it correlates with legacy
PROMs over a 6-month period, but we are unable to
predict long-term outcomes. However, a prior study
found that more than one-half of FAIS patients that
underwent hip arthroscopy achieved minimally
important clinical difference at the 6-month followup.18 In addition, our study population consisted of
primarily surgical patients; as such, we are unable to
evaluate the longitudinal correlation of PROMIS with
legacy hip measures in patients not being treated with
hip arthroscopy. Another limitation is that this is a
single surgeon series with procedures performed by a
high-volume hip arthroscopist, limiting us somewhat in
our generalizability. Finally, this study carries the
common limitations associated with a nonrandomized
retrospective study design, as well as from a small
sample size.

Conclusions
In patients at 6 months postoperatively from hip
arthroscopy for FAIS, iHOT-12 was the most responsive and had the largest effect size. In contrast,
PROMIS-PF had a lower effect size compared with
legacy hip-speciﬁc PROMs. Additionally, PROMIS-PF
did not correlate as well with iHOT-12 compared
with HOS-SS.

Table 6. Relative Efﬁciency Between Pre- and 6-Months Postoperative Outcome Measures
PROMIS Pain Interference
PROMIS Physical Function
HOS-ADL
HOS-SS
iHOT-12

PROMIS Pain Interference
0.96
1.75
1.03
3.95

PROMIS Physical Function
1.05
1.83
1.08
4.13

HOS-ADL
0.57
0.55
0.59
2.26

HOS-SS
0.97
0.93
1.70
3.84

iHOT-12
0.25
0.24
0.44
0.26
-

HOS-ADL, Hip Outcome Score-Activities of Daily Living; HOS-SS, Hip Outcome Score-Sports Subscale; iHOT-12, International Hip Outcome
Tool 12; PROMIS, Patient Reported Outcomes Measurement Information System.
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